SCHEMBL9833658

SCHEMBL9833658

CCC1C(=O)Nc2cc3[nH]c(N)nc3cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP6 P51161 2/20 0.43
PGR P06401 1/20 0.40
TYMS P04818 9/20 0.35
BACE1 P56817 2/20 0.35
PLAU P00749 1/20 0.35
HTR3E A5X5Y0 1/20 0.35
HTR3B O95264 1/20 0.35
HTR3A P46098 1/20 0.35
HTR3D Q70Z44 1/20 0.35
HTR3C Q8WXA8 1/20 0.35
ALDH1A1 P00352 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
ABL1 P00519 1/20 0.32
PNP P00491 1/20 0.32
MASP2 O00187 1/20 0.32
MEN1 O00255 1/20 0.32
NUDT1 P36639 1/20 0.32
KMT2A Q03164 1/20 0.32
AOC3 Q16853 1/20 0.32
AKT1 P31749 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9835234 0.84 PGR (0.40) PGRALDH1A1
SCHEMBL9834590 0.84 PGR (0.40) PGRALDH1A1
SCHEMBL9833156 0.82 FABP6 (0.46) FABP6PGRTYMSBACE1PLAU
SCHEMBL9836082 0.82 KDM4E (0.43) PGRALDH1A1MEN1KMT2AAKT1
SCHEMBL9835004 0.82 HPGD (0.40) PGRTYMSALDH1A1MEN1KMT2A
SCHEMBL9834766 0.82 KMT2A (0.48) PGRKMT2A
SCHEMBL9834606 0.81 KDM4E (0.45) PGRALDH1A1
SCHEMBL10374413 0.80 PGR (0.47) PGRALDH1A1MEN1KMT2A
SCHEMBL9833698 0.79 PGR (0.36) PGRTDP1MEN1KMT2A
SCHEMBL9834363 0.78 NPC1 (0.47) PGRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0214592-B1 PYRROLOBENZIMIDAZOLES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE PRODUCTS Roche Diagnostics GmbH (DE) 1991-08-14 EP disclosed
US-4730003-A Tricyclic compounds for treating heart and circulatory diseases BOEHRINGER MANNHEIM GMBH (DE) 1988-03-08 US disclosed
EP-0214592-A2 Pyrrolobenzimidazoles, process for their preparation and medicaments containing these products Roche Diagnostics GmbH (DE) 1987-03-18 EP disclosed